March 06, 2026

The Strategic Role of CRA AI Agents in Clinical Research

Using agentic AI to reduce clinical trial inefficiency

The Medicine Maker

March 05, 2026

Hybrid AI Improves Cataract Diagnosis

Nature paper advocates for smarter cataract detection using novel hybrid AI approach

The Ophthalmologist

March 04, 2026

Advanced Practice Providers in Oncology Care: Consensus Principles for Clinical Practice Utilization

Discover how the integration of advanced practice providers in oncology is evolving and the principles that guide their essential roles in patient care. Source: NCCN.

JADPRO

March 04, 2026

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Explore the multifaceted case of Ms. Jones, a 54-year-old woman navigating her diagnosis of MGUS and the complexities of treatment decisions.

JADPRO

March 04, 2026

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

A study highlights the evolving role of advanced practice providers in radiation oncology, revealing gaps in training and the potential for improved patient care.

JADPRO

March 04, 2026

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

Baptist Health South Florida

March 04, 2026

Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes

A new analysis spanning more than 3 decades of Eastern Cooperative Oncology Group and American College of Radiology Imaging Network (ECOG-ACRIN) clinical trial data demonstrates that Black patients wi...

The ASCO Post

March 04, 2026

HEK293 Cell Line for rAAV Manufacturing

New study reports two-fold improvement in full-to-empty rAAV ratio versus commercial HEK293 line

The Medicine Maker

March 03, 2026

Miami Cancer Institute Leads Landmark Phase 2 Glioblastoma Trial

The randomized Phase 2 CRUX-2 trial (Ruxolitinib in Combination with Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma) is currently recruiting.

Baptist Health South Florida

March 02, 2026

Pediatricians at the Perioperative Helm

Pediatricians “uniquely positioned” to take active role in preanesthesia planning, says revised American Academy of Pediatrics report

Conexiant